Showing 11-20 of 38 grants

Title Institution Researcher Program Duration Total Award Amount
Picosecond Infrared Laser (PIRL)-based spatial imaging mass spectrometry (proteomics) and transcriptomics of beta-cells in live human pancreas slices afflicted by T1D T-cell immune injury The Governing Council of the University of Toronto Herbert Gaisano Cures 01-April-2026 to 31-March-2027 $199,430.00
mRNA/LNP-based Epigenetic Immunomodulation to Restore Tolerance in T1D The Governing Council of the University of Toronto BOWEN LI Cures 01-April-2026 to 31-March-2027 $199,998.79
Tirzepatide with fully automated insulin delivery The Research Institute of the McGill University Health Centre Ahmad Haidar Improving Lives 01-September-2025 to 31-August-2028 $1,885,343.91
Developing a Curriculum and eLearning Course for Clinicians Delivering Cell Therapies for People with Type 1 Diabetes The University of Alberta Peter Senior Cures 01-January-2026 to 31-December-2027 $399,594.73
AI-driven benchmarking for understanding and improving SC-islets The University of Alberta Patrick MacDonald Cures 01-May-2025 to 30-April-2028 $750,000.00
Combinatory Technologies to Optimized Localized Drug Delivery for Cell Therapies in T1D The University of Alberta Gregory Korbutt Cures 01-July-2024 to 30-June-2027 $896,925.01
Graft localized therapeutic delivery systems to enhance beta cell engraftment The University of Alberta Gregory Korbutt Cures 01-October-2023 to 30-September-2026 $974,655.00
Implementing a virtual care platform to improve mental health for type 1 diabetes in rural and remote regions of Interior British Columbia The University of British Columbia Tricia Tang Improving Lives 01-April-2020 to 30-January-2026 $393,786.60
Using a virtual care platform to deliver peer-led mental health support to rural and remote communities in BC: A randomized wait-list controlled trial of the REACHOUT intervention The University of British Columbia Tricia Tang Improving Lives 01-September-2022 to 31-December-2026 $402,429.50
RREB1 and Ras signalling in cytokine-induced beta cell death The University of British Columbia Nicole Krentz Cures 01-March-2026 to 28-February-2031 $1,000,000.00